[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100605333":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":10,"responsibleParty":26,"collaborators":10,"id":28,"slug":29,"hasResults":30,"nctId":31,"briefTitle":32,"officialTitle":33,"acronym":34,"eligibilityCriteria":35,"healthyVolunteers":30,"sex":36,"minAge":10,"maxAge":10,"enrollmentInfo":37,"targetDuration":10,"studyType":40,"phases":10,"briefSummary":41,"conditions":42,"keywords":50,"overallStatus":52,"whyStopped":10,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":10},{"fullName":5,"class":6},"Oticon Medical","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Sentio",null,"Patients recieving the Sentio system",[13],"Device: Transcutaneous bone conduction hearing system",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","Transcutaneous bone conduction hearing system","The Sentio system is an active transcutaneous bone conduction hearing system (single armed study)",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Kia N Iversen, PhD","CONTACT","+46760039141","kinv@oticonmedical.com",{"type":27,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100605333","sentio-systematic-evaluation-100605333",false,"NCT07161154","Sentio Systematic Evaluation","Sentio Systematic Evaluation - SENSE","SENSE","Inclusion Criteria:\n\n* Subject who is scheduled for or have undergone Sentio implantation in clinical practice.\n* Subject who has consented to participation or are covered by consent waiver.\n\nExclusion Criteria:\n\n* Subjects enrolled in other clinical investigations leading to their Sentio implantation and subsequent follow-up deviating substantially from clinical practice","ALL",{"count":38,"type":39},100,"ESTIMATED","OBSERVATIONAL","The study is designed as an international, multi-center, single-armed, non-interventional\u002Fobservational study including subjects who has received or are planned to receive the Sentio system as part of normal clinical practice.",[43,44,45,46,47,48,49],"Hearing Loss, Bilateral or Unilateral","Hearing Loss, Conductive","Hearing Loss, Mixed Conductive-Sensorineural","Single Sided Deafness","Hearing Loss","Hearing-Impairment","Hearing Aid",[51],"Active transcutaneous bone conduction hearing system","NOT_YET_RECRUITING","2025-09-03",{"date":55,"type":56},"2025-09-08","ACTUAL",{"date":58,"type":39},"2025-09",{"date":60,"type":39},"2035-12",{"name":5,"class":6}]